Clinical Studies
Developing new treatments is important for continually improving patient care. Please click on the following links to learn more about KalVista's clinical trials:
KVD824-201 (KOMPLETE Study) is a Phase 2 clinical trial to evaluate KVD824 for the prevention of hereditary angioedema (HAE) attacks.
KVD900-301 (KONFIDENT Study) is a Phase 3 clinical trial to evaluate sebetralstat for the on-demand treatment of hereditary angioedema (HAE) attacks.